Edwards Lifesciences Lunch Symposia
Edwards Lifesciences Symposia
Explore cutting-edge topics at our two lunch symposia. Gain insights from leading experts and engage in impactful discussions. Be sure to check out the full agenda below and save the dates in your calendar!
Thursday 10 Oct 2024
Aortic regurgitation: Treating patients across the spectrum
Moderator: Filip Casselman, Belgium
The burden of aortic regurgitation
Real-world data: Bioprosthetic valve replacement for aortic regurgitation
Navigating the Ross procedure: Current insights
Aortic regurgitation and root dilatations: Valve sparing, bioprosthetic conduits, and more
Friday 11 Oct 2024
New frontiers in mitral valve replacement
Moderators: Marjan Jahangiri, United Kingdom and Vinod Thourani, United States
From North to South and East to West: Mitral valve replacement in motion
Evidence on MIS: Show me the data
ERAS in mitral valve surgery: The next big thing?
Mitral valve replacement: What can we learn from the aortic side?
Seeking continuous learning?
Download Edwards Masters App.
No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.
Refer to device instructions for use for important warnings related to VFit technology. These features have not been observed in clinical studies to establish the safety and effectiveness of the model 11500A for use in ViV procedures. VFit technology is available on sizes 19–25 mm.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).